Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir.
Sign Up to like & getrecommendations! Published in 2017 at "Gastroenterology"
DOI: 10.1053/j.gastro.2016.10.017
Abstract: BACKGROUND & AIMS Elbasvir (an NS5A inhibitor) and grazoprevir (an NS3/4A protease inhibitor) are direct-acting antiviral agents recently approved in the United States for treatment of chronic hepatitis C virus (HCV) genotype 1 and 4… read more here.
Keywords: grazoprevir; elbasvir grazoprevir; treatment; hcv genotype ... See more keywords
Meta-Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection.
Sign Up to like & getrecommendations! Published in 2018 at "Annals of hepatology"
DOI: 10.5604/01.3001.0010.7532
Abstract: BACKGROUND AND AIM Grazoprevir is an NS3/4A protease inhibitor (PI), while elbasvir is an NS5A inhibitor. We performed this meta-analysis to directly compare grazoprevir plus elbasvir and ribavirin regimen vs. grazoprevir and elbasvir without ribavirin… read more here.
Keywords: grazoprevir; analysis; treatment; grazoprevir plus ... See more keywords